Novo Nordisk Signs Diabetes R&D Pact
Novo Nordisk has formed a diabetes research collaboration with the Karolinska Institutet, a medical university in Sweden. In the new international post-doctoral fellowship program a total of 12 post-doctoral researchers will be offered a three-year grant to support their research primarily within the field of diabetes and metabolism. The research will be performed at Karolinska Institutet in Stockholm, Sweden, but there will also be possibility for research exchange performed at Novo Nordisk Research and Development in Denmark.
Novo Nordisk has research and development facilities in Denmark, US, China, and India. More than 6,000 employees are involved in research and development activities, many of them working in partnerships with external biotech and academic researchers.
A joint steering committee with members from both Karolinska Institutet and Novo Nordisk will oversee the program and will be responsible for recruiting researchers.The first four fellows in the program are expected to start in the autumn of 2015.
Source: Novo Nordisk